BridgeMD
New treatment option for Cannabis Use Disorder
Official title Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
ClinicalTrials.gov ID: NCT06085222
What this study is testing
- What it's testing
- The prevalence of daily cannabis use and Cannabis Use Disorder (CUD) has increased in the United States over the past two decades. Brief, computerized harm reduction interventions that target specific high-risk CUD populations could be an efficient approach to reducing CUD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30
You may be able to join if
- Cannabis is the primary substance of abuse.
- Clinical-level Distress intolerance Index score.
- Current Cannabis Use Disorder diagnosis.
- Near-daily to daily cannabis use in past-month and past 3 months.
- Positive urine screen for THC
You likely can't join if
- Presence of acute/major psychiatric disturbance
- Current pregnancy
- Change in psychotropic medication within the past month
- Concurrently receiving treatment for cannabis use
- Concurrently receiving dialectical behavior therapy or exposure-based therapy for emotional disorders
- Planning to immediately quit using cannabis
See the full eligibility criteria
- Cannabis is the primary substance of abuse.
- Clinical-level Distress intolerance Index score.
- Current Cannabis Use Disorder diagnosis.
- Near-daily to daily cannabis use in past-month and past 3 months.
- Positive urine screen for THC
- Detectable skin conductance level
- Owns a smart phone
- Primary smoked/vaporized delta-9 or delta-8 THC user
- Presence of acute/major psychiatric disturbance
- Current pregnancy
- Change in psychotropic medication within the past month
- Concurrently receiving treatment for cannabis use
- Concurrently receiving dialectical behavior therapy or exposure-based therapy for emotional disorders
- Planning to immediately quit using cannabis
- EEG contraindications
- Kidney disease
The study team makes the final eligibility decision.
Where it's taking place
- Tallahassee, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tallahassee, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.